Milind S. Deshpande's Insider Trades & SAST Disclosures

Milind S. Deshpande's most recent trade in Spero Therapeutics Inc was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on May 29, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Spero Therapeutics Inc
Milind S. Deshpande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 20,000 71,454 (0%) 0% 0 Common Stock
Spero Therapeutics Inc
Milind S. Deshpande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 15,000 31,454 (0%) 0% 0 Common Stock
Spero Therapeutics Inc
Milind S. Deshpande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2021 7,500 7,500 - - Stock Option (right to buy)
Spero Therapeutics Inc
Milind S. Deshpande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 2,629 2,629 - - Stock Option (right to buy)
Spero Therapeutics Inc
Milind S. Deshpande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Oct 2020 7,500 7,500 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades